Avanos shareholders approve all proposals at 2025 annual meeting, including 2.25M share increase for LTIP

AVANOS MEDICAL, INC.

All five director nominees elected with 85.8% to 90.3% of votes cast; broker non-votes excluded.
Deloitte & Touche ratified as auditor for 2025 with 94.7% of votes cast in favor.
Say-on-pay advisory vote passed with 86.7% of votes cast for, 11.4% against.
Amendment to 2021 Long Term Incentive Plan approved: 2,250,000 new shares added to reserve.
93.6% of outstanding shares represented at the meeting; high quorum.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.